...
首页> 外文期刊>Cancer causes and control: CCC >Effects of mammographic density and benign breast disease on breast cancer risk (United States).
【24h】

Effects of mammographic density and benign breast disease on breast cancer risk (United States).

机译:乳房X线照片密度和乳腺良性疾病对乳腺癌风险的影响(美国)。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Having either a history of benign breast disease, particularly atypical hyperplasia or extensive mammographic breast density, is associated with increased breast cancer risk. Previous studies have described an association between benign breast disease histology and breast density. However, whether these features measure the same risk, or are independent risk factors, has not been addressed. METHODS: This case-control study, nested within the prospective follow-up of the Breast Cancer Detection Demonstration Project, evaluated both benign histologic and mammographic density information from 347 women who later developed breast cancer and 410 age- and race-matched controls without breast cancer. Multivariate logistic regression analyses provided maximum-likelihood estimates of the odds ratios (OR) and 95% confidence intervals (CI) to evaluate the relative risk of breast cancer associated with each exposure. RESULTS: Adjusting for mammographic density, the OR for atypical hyperplasia was 2.1 (95% CI: 1.3-3.6), and adjusting for benign breast histology, the OR for > or = 75% density was 3.8 (95% CI: 2.0-7.2). Women with nonproliferative benign breast disease and > or = 75% density had an OR of 5.8 (95% CI: 1.8-18.6), and women with < 50% density and atypical hyperplasia had an OR of 4.1 (95% CI: 2.1-8.0). CONCLUSIONS: In this study, both benign breast disease histology and the percentage of the breast area with mammographic density were associated with breast cancer risk. However, women with both proliferative benign breast disease and > or = 75% density were not at as high a risk of breast cancer due to the combination of effects (p = 0.002) as women with only one of these factors.
机译:背景:既有良性乳腺疾病史,特别是非典型增生史或广泛的乳腺钼靶乳房密度,都与乳腺癌风险增加有关。先前的研究描述了良性乳房疾病的组织学与乳房密度之间的关联。但是,这些功能是衡量相同的风险,还是独立的风险因素,尚未得到解决。方法:该病例对照研究嵌套在乳腺癌检测示范项目的前瞻性随访中,评估了347名后来患乳腺癌的妇女以及410名年龄和种族相匹配的无乳腺癌妇女的良性组织学和乳房X线密度信息。癌症。多元逻辑回归分析提供了比值比(OR)和95%置信区间(CI)的最大似然估计,以评估与每次暴露相关的乳腺癌的相对风险。结果:调整乳房X光检查密度,非典型增生的OR为2.1(95%CI:1.3-3.6),并调整乳腺良性组织学,>或= 75%密度的OR为3.8(95%CI:2.0-7.2) )。患有非增生性乳腺良性疾病且密度≥75%的女性的OR为5.8(95%CI:1.8-18.6),而密度小于50%且具有非典型增生的女性的OR为4.1(95%CI:2.1- 8.0)。结论:在这项研究中,乳腺良性疾病的组织学和乳腺密度占乳腺面积的百分比均与患乳腺癌的风险有关。但是,由于多种因素的综合作用(p = 0.002),患有增生性乳腺疾病且密度≥75%的女性患乳腺癌的风险不高,而仅具有这些因素之一的女性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号